Obalon Therapeutics

Home » Obalon Therapeutics

Secondary

Obalon Therapeutics

They are a vertically integrated medical device company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity.

Symbol

OBLN

Last Closing Price
$6.14

Shares
4,400,000

Effective Date
January 19, 2018

Underwriters
UBS Investment Bank, Canaccord Genuity, Stifel

To view the prospectus for Obalon Therapeutics, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253